Hims & Hers Gains, Abbott Slides, Allbirds Sinks

On this episode of Stock Movers:
- Hims & Hers shares are extending their advance for a second straight session, gaining as much as 8.4% on Thursday. The telehealth firm’s stock rallied 14% on Wednesday, after HHS Secretary Robert F. Kennedy Jr. said the FDA is seeking to remove 12 peptides from Category 2 restrictions
-Abbott (ABT) shares slide as much as 5.1% to the lowest intraday level since 2023 after the medical-devices firm cut its adjusted earnings per share guidance for the full year due to the impact of its acquisition of Exact Sciences. Abbott also gave profit guidance for the second quarter that fell short of expectations.
- Allbirds Inc.'s stock sank as much as 31% on Thursday after soaring more than 582% a day prior due to its pivot to artificial intelligence infrastructure. The company's pivot and the stock's reaction were met with incredulity, with analyst Dylan Carden calling Wednesday's surge "by any measure a Hail Mary" for a stock that has lost about 96% of its value since it went public in 2021.

See omnystudio.com/listener for privacy information.